These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27175711)

  • 1. Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention.
    Zheng J; Cheng J; Zhang Q; Qi C; Wang T; Xiao X
    Medicine (Baltimore); 2016 May; 95(19):e3696. PubMed ID: 27175711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the hemoglobin A1c level in non-diabetic patients undergoing percutaneous coronary intervention: a meta-analysis.
    Li Y; Li XW; Zhang YH; Zhang LM; Wu QQ; Bai ZR; Si J; Zuo XB; Shi N; Li J; Chu X
    Chin Med J (Engl); 2020 Sep; 133(18):2229-2235. PubMed ID: 32826614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Preoperative HbA1c Levels on the Postoperative Outcomes of Coronary Artery Disease Surgical Treatment in Patients with Diabetes Mellitus and Nondiabetic Patients: A Systematic Review and Meta-Analysis.
    Wang J; Luo X; Jin X; Lv M; Li X; Dou J; Zeng J; An P; Chen Y; Chen K; Mu Y
    J Diabetes Res; 2020; 2020():3547491. PubMed ID: 32190696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Hemoglobin A1c Levels in Postmenopausal Diabetic Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome.
    Lao Y; Feng L; Yuan Y; Zhang J; Huang X; Li M; Wu Z
    Med Sci Monit; 2018 Dec; 24():9399-9405. PubMed ID: 30587845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated hemoglobin and outcomes in diabetic patients with acute myocardial infarction after successful revascularization with stent placement: findings from the guthrie health off-label stent (GHOST) investigators.
    Singla A; Orshaw P; Boura J; Harjai KJ
    J Interv Cardiol; 2012 Jun; 25(3):262-9. PubMed ID: 22376172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
    Hwang JK; Lee SH; Song YB; Ahn J; Carriere K; Jang MJ; Park TK; Choi SH; Yang JH; Choi JH; Lee SH; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28373177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of the glycated hemoglobin levels and prognostic nutritional index as a prognostic marker in patients with acute coronary syndrome and type 2 diabetes mellitus.
    Sun S; Wang Y; Pang S; Wu X
    Lipids Health Dis; 2024 Jan; 23(1):12. PubMed ID: 38212760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes of percutaneous versus surgical coronary revascularization in patients with diabetes mellitus (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2015 Apr; 115(8):1063-72. PubMed ID: 25733384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the adverse clinical outcomes associated with fraction flow reserve-guided versus angiography-guided percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Bundhun PK; Yanamala CM; Huang F
    BMC Cardiovasc Disord; 2016 Dec; 16(1):249. PubMed ID: 27912739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention (HbA1c < 6.5% at 2 years) in type 2 diabetes mellitus combined with acute coronary syndrome: a 5-years follow-up study.
    Yang T; Fu P; Chen J; Fu X; Xu C; Liu X; Niu T
    Curr Med Res Opin; 2021 Sep; 37(9):1517-1528. PubMed ID: 34166166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation.
    Lemesle G; Bonello L; de Labriolle A; Maluenda G; Syed AI; Collins SD; Ben-Dor I; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Jul; 104(1):41-5. PubMed ID: 19576319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis.
    Bundhun PK; Huang F
    BMC Cardiovasc Disord; 2018 May; 18(1):78. PubMed ID: 29720092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
    Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; Suryapranata H; De Luca G;
    J Diabetes Complications; 2015; 29(4):517-22. PubMed ID: 25736187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
    Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
    Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
    Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of the mean hemoglobin A1c levels after percutaneous coronary intervention in patients with diabetes.
    Bae J; Yoon JH; Lee JH; Nam JH; Lee CH; Son JW; Kim U; Park JS; Shin DG
    Korean J Intern Med; 2021 Nov; 36(6):1365-1376. PubMed ID: 34645114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery?
    Tennyson C; Lee R; Attia R
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):1000-8. PubMed ID: 24021615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.